Table 1.
Characteristics of cases and controls in relation to GH administration
| Variable studied (unit) | Group I (n=127) | Group II (n=49) | P value |
|---|---|---|---|
| FSH Dosage (UI) | 2655±50.03 | 3214±132.70 | 0.0002 |
| Stimulus duration (days) | 9.60±0.12 | 10.55±0.17 | 0.0001 |
| E2 level (pg/mL) | 1243±44.42 | 983±76.77 | 0.0044 |
| Follicles > 16 mm (n) | 5.39±0.22 | 3.94±0.23 | 0.0001 |
| Recovered oocytes (n) | 3.89±0.25 | 2.67±0.21 | 0.0003 |
| Mature oocytes (n) | 3.03±0.22 | 2.33±0.19 | 0.0156 |
| Fertilized oocytes (n) | 2.42±0.19 | 2.08±0.19± | p>0.05 |
| Embryos A+B (n) | 1.64±0.14 | 1.20±0.12 | 0.0149 |
| Embryos C+D (n) | 0.74±0.11 | 0.90±0.14 | p>0.05 |
| Cycles that achieved transfer (n) | 0.61±0.04 | 0.75±0.06 | p>0.05 |
| Transferred embryos (n) | 1.27±0.10 | 1.55±0.16 | p>0.05 |
| Frozen embryos (n) | 0.31±0.08 | 0.24±0.09 | p>0.05 |
Group I – Cases;
Group II – Controls;
FSH – Follicle Stimulation Hormone;
E2 - estradiol;